mRNA Vaccine For Pancreatic Cancer Continues To Show Promise
An mRNA vaccine for pancreatic cancer developed at Memorial Sloan Kettering has shown promise in early trials. Half of the sixteen patients in a small safety trial had a strong immune response, and a follow-up study found no cancer relapse in six patients after three years. The…